Research
The department is very research active with
dedicated research nurses and a registrar. We regularly participate
in national clinical trials, which have recently included a large
UK wide study investigating the best treatment for alcohol related
liver disease. These trials also allow us to offer our patients
access to the most up to date treatments, including the AlphaPump
(a novel way of treating ascites) and ELAD (a liver life support
machine). We are also actively recruiting patients into several
studies investigating the best way in which to treat liver cancer.
Because of our research activity, we are also now able to offer
access to the new medications that are now available to treat
hepatitis C.
Previous and current studies we have been involved in
include:
ATTIRE; A study on using Albumin to prevent infection
in chronic liver failure.
ASqoL: Protocol for a prospective cohort study to
develop and validate AScites Quality of Life
questionnaire
COBALT: A study of Obeticholic Acid evaluating clinical outcomes
in patients with Primary Biliary Cholangitis
Cosmic 312 - A study into advanced
hepatocellular carcinoma who have not received previous systemic
anticancer therapy
ISIAH: A trial is to explore the
potential benefits of the IL-1β antibody, Canakinumab (solution for
injection), in the treatment of alcoholic hepatitis
